Red wine is known to have multiple health benefits. Researchers at the University of Missouri-Columbia have found that red wine may also protect humans from common food-borne diseases.
A research team combining high-energy physicists from the University of California, Santa Cruz, and neuroscientists from the Salk Institute in La Jolla, Calif., has discovered a type of retinal cell that may help monkeys, apes, and humans see motion. The team’s work appears in the October 10 issue of Journal of Neuroscience.
Alcohol-dependent patients who received the medication topiramate had fewer heavy drinking days, fewer drinks per day and more days of continuous abstinence than those who received placebo, according to a study in the Oct. 10 issue of JAMA.
In a study published in the Journal of Women’s Health, researchers from the Centers for Disease Control and Prevention and Thomson Healthcare (NYSE: TOC; TSK: TOC) found a distinct pattern of medical signs and symptoms that occurred prior to the detection of ovarian cancer.
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced grants totaling more than $80 million over the next four years to expand the ENCyclopedia Of DNA Elements (ENCODE) project, which in its pilot phase yielded provocative new insights into the organization and function of the human genome.
The Stop TB Partnership’s Global Drug Facility and UNITAID announced a collaboration with 19 countries to address life-threatening shortages of anti-tuberculosis drugs.
Cornell University engineers say they have developed a microvascular system that can nourish growing tissues, a step that may one day allow laboratories to grow synthetically engineered tissues for transplants.
Depression in the elderly increases the risk of subsequent mental impairment and can act as a predictor of future intellectual decline, University of Rochester Medical Center psychiatrists and researchers have found.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that Japan’s Ministry of Health, Labour and Welfare has approved ELAPRASE, a human enzyme replacement therapy for the treatment of Hunter syndrome, for sale and marketing in Japan. Since its U.S. approval in July 2006, ELAPRASE is now approved for marketing and commercial distribution in 34 countries worldwide.
Scientists have identified and described stem cells specific to several tissues and organs of the body — key master cells that give rise to the specialized cell types characteristic of that organ. But to date, it hasn’t been possible to pinpoint functioning stem cells in the stomach, either in laboratory animals or people.